PITTSBURGH, March 2, 2025 /PRNewswire/ -- TRAiNED, Inc., a pioneering technology firm at the forefront of artificial intelligence (AI) solutions in mortgage processing, is excited to announce the launch of its investment opportunity on StartEngine. This initiative seeks to transform the traditional mortgage manufacturing process, making it faster, more cost-effective, and less cumbersome for lenders and borrowers alike.Disrupting the Mortgage Industry with Advanced AI The mortgage sector has long been challenged by high costs and inefficiencies, with the average cost of loan manufacturing exceeding $11,000. TRAiNED's innovative AI technology addresses these challenges by automating critical aspects of the mortgage process, including document verification and data transfer to Loan Origination Systems (LOS). This automation significantly reduces manual labor, cuts costs, and speeds up the lending process.A Commitment to Inclusive Employment Central to TRAiNED's strategy is its commitment to social responsibility, particularly through employing neurodivergent individuals who specialize in training AI functions. This initiative not only advances technological innovation but also creates valuable employment opportunities for a group that is often underrepresented in the workforce.Investment Opportunity Now Open TRAiNED's campaign on StartEngine allows individual investors to participate in the future of mortgage processing technology with investments starting at just $1,000. This convertible note offering is designed to fund further development and market expansion of TRAiNED's AI solutions in 2025 and beyond.Industry and Investor Enthusiasm Since its inception in 2022, TRAiNED has gained significant traction within the mortgage industry:Signed 15 lenders, managing almost 40,000 annual loans.Generated over $1,000,000 in Annual Recurring Revenue (ARR) from new customers in less than a year.in Annual Recurring Revenue (ARR) from new customers in less than a year

Future Cardia, a med-tech innovator, is transforming cardiac monitoring with its implantable device, raising significant funds to enhance heart failure management.

/PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug dispensing technology to enhance...